Answers are grounded in this paper and cite their sources.
The paper establishes certification standards for AI governance and liability quantification, highlighting implications for multiple sectors.
This paper establishes two new certification standards for AI governance and introduces a complete framework for AI Liability Quantification (ALQ). The Authority Confidence Rating (ACR) is a cryptographic standard for quantifying AI decision authorization in real time. The Authority Confidence Deficit (ACD) is a derived liability variable enabling insurers to price AI liability from cryptographic enforcement data. ACR Certification provides a four-tier classification (Platinum, Gold, Silver, Unrated). ACR-Zero Certification provides a structural designation where unauthorized execution is eliminated. The paper describes how ACR and ACD are computed natively across the Y.I.N. Mazari Architecture: a 44-layer system organized into nine tiers spanning from physics foundation through certification output, including 38 governance layers, 4 hardware enforcement layers (YIN KEYSTONE, 520 claims), and 2 certification output layers. A complete 44-layer architecture table is provided. The Y.I.N. Mazari Architecture is currently the only architecture spanning all 44 layers and the only architecture qualifying for ACR-Zero Certification. The complete architecture is protected by 40 USPTO patent applications comprising 4,300+ claims with priority date November 23, 2025. Four application domains are identified: insurance underwriting, regulatory compliance under the EU AI Act and Product Liability Directive 2024/2853, defense operations including real-time mission authorization monitoring, and enterprise AI procurement. This paper extends the ACR standard published as a companion record (DOI: 10.5281/zenodo.19361421). Implementation using cryptographic authority enforcement may require licensing from the inventor. Licensing inquiries: ilyesmazari@hotmail.com
No takes yet. Share an insight, caveat, or question.
Ilyes Tarik Mazari (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: